RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still urgently needed. Advent of next-generation sequenci...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bfdf39e3e7f3450d90d8cdf0f18f3cf7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bfdf39e3e7f3450d90d8cdf0f18f3cf7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bfdf39e3e7f3450d90d8cdf0f18f3cf72021-11-25T17:07:58ZRNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing10.3390/cells101128502073-4409https://doaj.org/article/bfdf39e3e7f3450d90d8cdf0f18f3cf72021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2850https://doaj.org/toc/2073-4409Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still urgently needed. Advent of next-generation sequencing technologies has allowed identification of novel genes and mutations associated with neuromuscular pathologies, highlighting splicing defects as essential players. Deciphering the significance and relative contributions of defective RNA metabolism will be instrumental to address and counteract these malignancies. We review here recent progress on the role played by alternative splicing in ensuring functional neuromuscular junctions (NMJs), and its involvement in the pathogenesis of NMJ-related neuromuscular disorders, with particular emphasis on congenital myasthenic syndromes and muscular dystrophies. We will also discuss novel strategies based on oligonucleotides designed to bind their cognate sequences in the RNA or targeting intermediary of mRNA metabolism. These efforts resulted in several chemical classes of RNA molecules that have recently proven to be clinically effective, more potent and better tolerated than previous strategies.Veronica VerdileGloria GuizzoGabriele FerranteMaria Paola ParonettoMDPI AGarticlealternative splicingneuromuscular diseaseRNA-based therapiesBiology (General)QH301-705.5ENCells, Vol 10, Iss 2850, p 2850 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
alternative splicing neuromuscular disease RNA-based therapies Biology (General) QH301-705.5 |
spellingShingle |
alternative splicing neuromuscular disease RNA-based therapies Biology (General) QH301-705.5 Veronica Verdile Gloria Guizzo Gabriele Ferrante Maria Paola Paronetto RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing |
description |
Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still urgently needed. Advent of next-generation sequencing technologies has allowed identification of novel genes and mutations associated with neuromuscular pathologies, highlighting splicing defects as essential players. Deciphering the significance and relative contributions of defective RNA metabolism will be instrumental to address and counteract these malignancies. We review here recent progress on the role played by alternative splicing in ensuring functional neuromuscular junctions (NMJs), and its involvement in the pathogenesis of NMJ-related neuromuscular disorders, with particular emphasis on congenital myasthenic syndromes and muscular dystrophies. We will also discuss novel strategies based on oligonucleotides designed to bind their cognate sequences in the RNA or targeting intermediary of mRNA metabolism. These efforts resulted in several chemical classes of RNA molecules that have recently proven to be clinically effective, more potent and better tolerated than previous strategies. |
format |
article |
author |
Veronica Verdile Gloria Guizzo Gabriele Ferrante Maria Paola Paronetto |
author_facet |
Veronica Verdile Gloria Guizzo Gabriele Ferrante Maria Paola Paronetto |
author_sort |
Veronica Verdile |
title |
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing |
title_short |
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing |
title_full |
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing |
title_fullStr |
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing |
title_full_unstemmed |
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing |
title_sort |
rna targeting in inherited neuromuscular disorders: novel therapeutic strategies to counteract mis-splicing |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/bfdf39e3e7f3450d90d8cdf0f18f3cf7 |
work_keys_str_mv |
AT veronicaverdile rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing AT gloriaguizzo rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing AT gabrieleferrante rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing AT mariapaolaparonetto rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing |
_version_ |
1718412739058073600 |